Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A non-bronchoconstrictor, bacteriostatic preservative for nebuliser solutions.

Q A Summers1, M R Nesbit, R Levin

  • 1Immunopharmacology Group, University of Southampton.

British Journal of Clinical Pharmacology
|February 1, 1991
PubMed
Summary

Chlorocresol and chlorbutol preservatives effectively inhibit microbial growth in nebuliser solutions. Studies on eight asthmatic patients showed no adverse pulmonary function changes, indicating their safety for respiratory treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-specific quality assurance failure prediction with deep tabular models.

Biomedical physics & engineering express·2023
Same author

Antibiotics increase aggression behavior and aggression-related pheromones and receptors in <i>Drosophila melanogaster</i>.

iScience·2022
Same author

First Report of Meloidogyne partityla on Pecan in Florida.

Plant disease·2019
Same author

KidsBrainIT: A New Multi-centre, Multi-disciplinary, Multi-national Paediatric Brain Monitoring Collaboration.

Acta neurochirurgica. Supplement·2018
Same author

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study.

Lupus·2016
Same author

Frailty and osteoporosis in older women--a prospective study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013

Area of Science:

  • Pharmaceutical Science
  • Respiratory Medicine

Background:

  • Nebuliser solutions require effective preservatives to prevent microbial contamination.
  • Chlorocresol and chlorbutol are commonly used preservatives with potential respiratory applications.

Purpose of the Study:

  • To evaluate the bacteriostatic efficacy of chlorocresol and chlorbutol against common microbes.
  • To assess the safety and potential adverse effects of these preservatives on airway function in asthmatic individuals.

Main Methods:

  • Bacteriostatic activity was determined using standard microbiological techniques over 28 days.
  • Airway effects were assessed in eight asthmatic subjects by measuring FEV1 (Forced Expiratory Volume in 1 second) for 60 minutes post-inhalation of preservatives or placebo.

Main Results:

Related Experiment Videos

  • Both chlorocresol and chlorbutol demonstrated significant bacteriostatic properties, inhibiting bacterial and yeast growth for 28 days.
  • No statistically significant changes in FEV1 were observed in asthmatic subjects following inhalation of either preservative compared to saline placebo.

Conclusions:

  • Chlorocresol and chlorbutol exhibit effective antimicrobial activity suitable for nebuliser solutions.
  • These preservatives appear safe for use in nebuliser solutions, showing no immediate negative impact on the pulmonary function of asthmatic patients.